News

Caboolture academic leads new research into irritable bowel syndrome

26 June 2012

A QUT research project has the potential to change the lives of people living with irritable bowel syndrome.

The project, which examines the role of the gastrointestinal tract microbiota and chronic infections in irritable bowel syndrome (IBS), has recently secured funding through the competitive 2012 Princess Alexandra Research Foundation and Private Practice Trust Fund.

Led by Dr Adam Polkinghorne, a science lecturer at QUT's Caboolture campus, a team of researchers will use molecular and clinical methods to investigate cohorts of patients with differing presentations of IBS.

"The exact causes of IBS are unknown, however recent data has suggested subtle changes in gastrointestinal microbiota occur in patients with IBS, with a recent study finding significant differences in the mucosal communities, rather than the faecal ones."

"Our project will systematically explore the role of shifts in the microbiota and identify potential bacterial causes which may be treated on the basis of the bacterial infection."

Dr Polkinghorne said the research had the potential to affect future diagnosis and treatment of IBS, and enhance the quality of life for many Australian sufferers.

"Gastrointestinal disorders are highly prevalent, impact negatively on quality of life and present a significant health burden," he said.

"With unknown causes and ineffective treatments in most patients, it is a major health issue for the community," he said.

Head of Campus at QUT Caboolture, Robert Craig highlighted the benefits of having Dr Polkinghorne teaching at the campus.

"The research Adam is doing brings added value to the classroom"

"The students have the opportunity to learn from a research active scientist and the fact that he can apply theories to real world situations makes for an enriched learning experience," he said.

To learn more about QUT's Infectious Disease research, visit www.ihbi.qut.edu.au